Last week, the Director General, of Nigeria’s National Agency for Foods, Drugs Administration and Control, NAFDAC, Paul Orhii, said less than 30 percent of essential medicines used in Nigeria was produced domestically, reports the local newspaper Vanguard. Dr Orhii said this when he received a delegation of Sierra Leone food and drugs regulators in Abuja.
He said: "One of the factors that encourage fake and substandard drugs in Nigeria is that we have low manufacturing capacity. What I did when I came in was to encourage our local manufacturers to increase production and also to upgrade facilities to meet international standards and most of them responded."
However, he pointed out that a few of the pharmaceutical companies in the country might obtain World Health Organization pre-qualification before the end of this year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze